查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1616815

全球癌症登记软体市场规模（按类型、部署模型、资料库、功能、最终用户、地区、范围和预测）

Global Cancer Registry Software Market Size By Type, By Deployment Model, By Database, By Functionality, By End-User, By Geographic Scope And Forecast
出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3个工作天内

价格
简介目录

癌症登记软体市场规模及预测

2023年癌症登记软体市场规模为8,182万美元，预计2024年至2031年复合年增长率为10.33%，2031年达到1.7964亿美元。癌症登记软体是一种专门的电脑应用程序，旨在收集、储存和管理大量有关癌症患者的资料。这些应用程式在医疗保健领域非常重要，因为它们允许建立有组织的资料库，其中包含有关个别癌症病例、治疗方法、患者属性和结果的资讯。癌症登记软体是医疗保健专业人员研究和追踪癌症发生率、盛行率和存活率趋势的中央储存库。

其主要目的是透过提供有关癌症诊断和治疗的准确、最新资讯来推进癌症研究、患者护理和公共卫生举措。

这些软体应用程式是癌症登记处的重要工具，使医疗机构能够在国家和全球平台之间传输关键数据，以便更好地瞭解和对抗癌症。

癌症登记软体市场动态

塑造癌症登记软体市场的主要市场动态

主要市场推动因素

癌症发生率上升：

随着癌症诊断领域的不断发展，对组织和评估随附资料的有效工具的需求不断增长。癌症登记软体在这方面非常重要，是一个关键的市场推动因素，因为它提供了一个准确报告、监测和调查的平台，最终实现了更强有力的癌症控制。

加强优质照护和临床研究：

对提高服务品质和支援临床研究的重视也推动了癌症登记软体的采用。这些技术有助于提高数据准确性、治疗计划和资源分配，进而改善患者的治疗效果。

数据驱动的决策与公共卫生监测：

这些系统的数据为公共卫生政策和举措提供信息，从而实现更有针对性的预防和早期检测计划。这有利于地方和国家层级的风险评估、资源分配和癌症趋势追踪。因此，数据驱动的决策和公共卫生监测正在推动癌症登记软体的使用。

主要挑战

与现有医疗保健 IT 系统整合：

由于不同的数据标准和供应商锁定，将癌症登记软体与现有的医疗保健 IT 系统（尤其是电子健康记录 (EHR)）整合极为困难。与互通性相关的复杂性对于获得对癌症模式和治疗结果的完整和一致的瞭解至关重要，并对癌症註册软体市场的成长提出了挑战。

高初始投资：

开发和维护癌症登记软体所需的高昂初始成本对于小型医疗机构来说尤其具有挑战性。平衡实施癌症登记软体的成本与长期效益仍然是医疗保健组织面临的主要挑战。

新的技术挑战：

将人工智慧 (AI) 和机器学习 (ML) 整合到现有工作流程中，同时保护病患隐私和资料完整性是一项需要智慧解决方案的挑战。因此，将人工智慧和机器学习整合到癌症登记软体中既会带来机遇，也会带来障碍。

主要趋势

强调患者的治疗结果：

癌症登记软体正在兴起，透过为医生提供即时数据和见解来做出更有针对性的治疗决策，以支持个人化医疗的目标。透过患者入口网站和行动应用程式等功能，患者互动变得越来越重要。

基于云端的部署将成为推动因素：

医疗保健公司越来越多地转向基于云端的解决方案，因为它们提供了更大的灵活性、可扩展性和可访问性。由于成本降低和 IT 基础设施要求降低，预计这一趋势将持续下去。

与人工智慧和机器学习整合：

人工智慧驱动的系统正在开发中，以实现肿瘤检测、分期和风险评估的自动化。这提高了数据准确性和效率，从而改善患者护理和研究结果。

癌症登记软体市场的区域分析

以下是癌症登记软体市场更详细的区域分析：

北美：

根据 Verified Market Research 的数据，由于癌症发生率高、医疗基础设施发达、政府支持和先进的技术实施方法，北美将在预测期内主导癌症登记软体市场。

北美拥有发达的医疗基础设施和强大的政府资助，使其成为实施癌症登记软体等尖端技术的理想环境。

在这个不断发展的行业中，北美正在优先考虑电子健康记录 (EHR) 整合、采用人工智慧驱动的分析以及全面的数据洞察等关键领域，以推动个人化护理。EHR 整合可确保统一且全面的病患记录系统，简化资讯流并提高医疗保健服务的整体效率。

此外，IT 实施的改进使得将癌症登记软体整合到现有医疗保健系统中变得更加容易，从而巩固了该地区作为 IT 解决方案热衷用户的地位。

欧洲：

欧洲癌症登记软体产业的成长是由多种因素推动的，包括癌症发病率上升、强大的医疗保健系统、政府鼓励癌症登记的要求以及对资料保护和互通性的承诺。

欧洲拥有优秀的医疗保健系统，该系统依赖实证方法并专注于公共卫生。癌症登记软体整合符合这些概念，并为医疗保健产业的实证决策、资源分配和策略规划奠定了基础。

该地区对现代、可互通的癌症登记解决方案的渴望不仅是因为强调确保健康资讯系统的顺利通讯和集成，而且还因为严格的资料隐私要求。

此外，该地区癌症发生率的上升也增加了对先进系统有效收集、组织和分析癌症相关数据的需求。

亚太地区：

由于癌症发病率上升、医疗保健支出大幅增加、政府大力加强医疗保健基础设施以及数位医疗技术的加速采用，亚太地区处于全球数据的前沿，预计将成为该地区成长最快的市场。

该地区数位医疗技术的使用正在增加。在医疗保健中使用数位技术（例如癌症登记软体）有助于高效的数据管理，改善医疗保健专业人员之间的协作，并促进基于证据的决策。

此外，生活方式的改变、预期寿命的延长和环境变数都会导致癌症发生率上升，因此需要专注于亚太地区的癌症管理和研究。

目录

第1章全球癌症登记软体市场：简介

  • 市场概况
  • 调查范围
  • 先决条件

第 2 章执行摘要

第3章 验证市场情报研究方法

  • 数据挖掘
  • 确认
  • 一次资料
  • 数据源列表

第4章癌症登记软体全球市场展望

  • 概述
  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会
  • 波特的五力模型
  • 价值链分析

第5章全球癌症登记软体市场：按类型

  • 概述
  • 整合软体
  • 独立软体

第6章全球癌症登记软体市场：按资料库

  • 概述
  • 商业资料库
  • 公共资料库

第7章全球癌症登录软体市场：依功能

  • 概述
  • 癌症报告
  • 病人护理管理
  • 产品成果评估
  • 医学研究和临床研究

第8章全球癌症登记软体市场：依最终用户分类

  • 概述
  • 政府机构和第三方控制者
  • 医院和诊所
  • 私人付款人
  • 製药、生技和医疗器材公司
  • 研究中心

第9章全球癌症登记软体市场：按地区

  • 概述
  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 亚太其他地区
  • 世界其他地区
    • 拉丁美洲
    • 中东/非洲

第10章全球癌症登记软体市场：竞争格局

  • 概述
  • 公司市场排名
  • 主要发展策略

第11章 公司简介

  • C/NET Solutions
  • IBM Corporation
  • Siemens Healthineers
  • McKesson Corporation
  • Elekta
  • Epic Systems
  • Cerner Corporation

第12章 主要进展

  • 产品发布/开发
  • 併购
  • 业务拓展
  • 伙伴关係和联盟

第13章附录

  • 相关研究
简介目录
Product Code: 7549

Cancer Registry Software Market Size And Forecast

Cancer Registry Software Market size was valued at USD 81.82 Million in 2023 and is projected to reach USD 179.64 Million by 2031, growing at a CAGR of 10.33% from 2024 to 2031. Cancer registry software is a type of specialized computer application that is designed to collect, store, and manage extensive data about cancer patients. These applications are important in healthcare because they allow for the establishment of organized databases containing information about individual cancer cases, treatment modalities, patient demographics, and results. Cancer registry software is a central repository for medical professionals to study and track trends in cancer incidence, prevalence, and survival rates.

The primary goal is to promote cancer research, patient care, and public health initiatives by providing accurate and current information about cancer diagnosis and treatments.

These software applications are critical tools for cancer registries, allowing healthcare organizations to transfer vital data across national and worldwide platform to better understand and combat cancer.

Cancer Registry Software Market Dynamics

The key market dynamics that are shaping the Cancer Registry Software Market include:

Key Market Drivers

Rising Cancer Burden:

With an increasing global prevalence of cancer diagnoses, there is a greater demand for effective tools to organize and evaluate the accompanying data. Cancer registry software is critical in this context because it provides a platform for accurate reporting, monitoring, and research, ultimately leading to enhanced cancer control measures, thereby serving as a key market driver.

Enhanced Quality Care and Clinical Research:

The emphasis on improving service quality and supporting clinical research has also aided in the adoption of cancer registry software. These technologies help to enhance data accuracy, treatment planning, and resource allocation, leading to better patient outcomes.

Data-Driven Decision-Making and Public Health Surveillance:

These systems' data feed public health policies and initiatives allow for more targeted preventative and early detection programs. This, in turn, facilitates risk assessment, resource allocation, and cancer trend tracking at the regional and national levels. As a result, data-driven decision-making and public health surveillance are driving the use of cancer registry software.

Key Challenges:

Integration with Existing Healthcare IT Systems:

The integration of cancer registry software with existing healthcare IT systems, particularly electronic health records (EHRs), is extremely difficult due to different data standards and vendor lock-in. The complexity associated with interoperability is critical to getting full and coherent insights into cancer patterns and treatment results, thereby challenging the growth of the Cancer Registry Software Market.

High Upfront Investment:

The significant initial cost necessary to develop and maintain cancer registry software presents a difficulty, especially for smaller healthcare organizations. Balancing the expenses of deploying cancer registry software compared to the possible long-term benefits remains an important consideration for healthcare institutions.

Emerging Technological Challenges:

Integrating artificial intelligence (AI) and machine learning (ML)into existing workflows while maintaining patient privacy and data integrity presents a challenge that necessitates smart solutions. Thus, integrating AI and ML into cancer registry software creates both potential and obstacles.

Key Trends:

Focus on Patient Outcomes:

Cancer registry software is emerging to support personalized medicine ambitions by providing doctors with real-time data and insights to make more tailored treatment decisions. Patient interaction is becoming increasingly important, with features such as patient portals and mobile apps as a key trend in the market.

Cloud-Based Deployment Gaining Traction:

Healthcare organizations are increasingly turning to cloud-based solutions because they offer greater flexibility, scalability, and accessibility. This trend is projected to continue, driven by cost savings and lower IT infrastructure requirements.

Integration with AI and Machine Learning:

AI-powered systems are being developed to automate tumor detection, staging, and risk assessment. This can increase data accuracy and efficiency, resulting in better patient care and research findings.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Cancer Registry Software Market Regional Analysis

Here is a more detailed regional analysis of the Cancer Registry Software Market:

North America:

According to Verified Market Research, North America is estimated to dominate in Cancer Registry Software Market during the forecast period owing to the region's high cancer burden, well-established healthcare infrastructure, government support, and a forward-thinking approach to technology adoption.

The well-developed healthcare infrastructure in North America, combined with significant government financing initiatives is creating an atmosphere suitable for the adoption of modern technology such as cancer registry software.

In this growing industry, North America prioritizes critical areas such as integrating with Electronic Health Records (EHRs), employing AI-powered analytics, and advancing personalized treatment through comprehensive data insights. Integration with EHRs ensures a unified and comprehensive patient record system, which streamlines information flow and improves overall healthcare delivery efficiency.

Furthermore, the region's dedication to leverage IT solutions strengthens its position, since improved IT adoption allows for the easy integration of cancer registry software into existing healthcare systems.

Europe:

The rise in the cancer registry software industry in Europe has been attributed to several factors, including rising cancer incidence, strong healthcare systems, governmental requirements encouraging cancer registries, and a dedication to data protection and interoperability.

Europe boasts excellent healthcare systems that rely on evidence-based methods and focus on public health. The integration of cancer registry software is consistent with these concepts, laying the groundwork for evidence-based decision-making, resource allocation, and strategic planning in the healthcare industry.

The region's desire for modern, interoperable cancer registry solutions is influenced by stringent data privacy requirements as well as an emphasis on ensuring smooth communication and integration of health information systems.

Furthermore, the rising prevalence of cancer in the region has increased the need for sophisticated systems to efficiently collect, organize, and analyze cancer-related data.

Asia Pacific:

Asia-Pacific is estimated to be the fastest-growing market in the global data fabric environment, driven by the increasing prevalence of cancer, a significant uptick in healthcare spending, proactive government initiatives to bolster healthcare infrastructure, and the accelerating adoption of digital health technologies.

This region is seeing increased usage of digital health technologies. The use of digital technologies in healthcare, such as cancer registry software, aids efficient data administration, improves cooperation among healthcare professionals, and promotes evidence-based decision-making.

Furthermore, lifestyle changes, higher life expectancy, and environmental variables all contribute to the rising cancer rate, necessitating a greater emphasis on cancer management and research in Asia Pacific.

Global Cancer Registry Software Market: Segmentation Analysis

The Global Cancer Registry Software Market is segmented on the basis of Type, Deployment Mode, Database, Functionality, End-User, And Geography.

Cancer Registry Software Market, By Type

  • Integrated Software
  • Standalone Software

Based on Type, the market is segmented into Integrated Software and Standalone Software. The Standalone Software type segment is estimated to dominate the market over the forecast period. This growth is attributable to its extensive capability, easy-to-use features, and inherent adaptability. Standalone software solutions function independently of other systems, allowing healthcare organizations to customize and seamlessly integrate with existing infrastructures. These systems offer end users a dedicated platform for cancer registry maintenance, allowing for fast data gathering, analysis, and reporting.

Cancer Registry Software Market, By Deployment Mode

  • On-Premise
  • Cloud-Based

Based on Deployment Mode, the market is segmented into On-Premise and Cloud-Based. On-premise segment is estimated to dominate the Cancer Registry Software Market during the forecast period. Several factors contribute to the on-premise deployment segment's dominance in the Cancer Registry Software Market, including addressing the specific demands and preferences of healthcare institutions. The on-premise implementation offers a great level of control and flexibility, allowing healthcare companies to adjust the software to their specific needs while seamlessly integrating it with existing infrastructure. This level of personalization is especially important in the healthcare industry, where data security and adherence to regulatory norms are critical.

Cancer Registry Software Market, By Database

  • Commercial Databases
  • Public Databases

Based on the Database, the market is segmented into Commercial and Public Databases. The commercial database segment is estimated to hold a major share of the market during the forecast period. Commercial databases provide comprehensive and user-friendly solutions that address the complex needs of healthcare practitioners, researchers, and administrators. The Commercial Databases segment's dominance is further supported by their smooth integration capabilities, interoperability, and scalability, which allow them to meet the different needs of healthcare institutions and research organizations.

Cancer Registry Software Market, By Functionality

  • Cancer Reporting
  • Patient Care Management
  • Product Outcome Evaluation
  • Medical Research and Clinical Studies

Based on Functionality, the market is segmented into Cancer Reporting, Patient Care Management, Product Outcome Evaluation, Medical Research and Clinical Studies. The cancer reporting segment is estimated to hold the majority share in the forecast period in the Cancer Registry Software Market. Its vital function in aggregating and managing detailed data on cancer cases are enabling the segment retain its top position. Accurate and timely reporting of cancer information is critical for healthcare institutions, regulatory agencies, and researchers to understand disease patterns, assess treatment outcomes, and develop effective public health measures. Cancer reporting software accelerates data collection, organization, and analysis, assuring regulatory compliance and enhancing the overall quality of cancer-related information.

Cancer Registry Software Market, By End-User

  • Government Organizations & Third-party Administrators
  • Hospitals & Medical Practices
  • Pharmaceutical, Biotechnology, & Medical Device Companies
  • Private Payers
  • Research Centers

Based on End-User, the market is segmented into Government Organizations & Third-party Administrators, Hospitals & Medical Practices, Pharmaceutical, Biotechnology & Medical Device Companies, Private Payers, and Research Centers. The Government Organizations & Third-party Administrators segment is estimated to show the highest growth in the forecasted period. Government entities, such as public health agencies and regulatory authorities, play an important role in the collection, analysis, and dissemination of cancer-related data for public health research and policy. The necessity for comprehensive cancer registries is consistent with public health objectives such as disease trend monitoring, prevention planning, and resource allocation optimization.

Key Players

  • The "Global Cancer Registry Software Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are
  • C/NET Solutions, IBM Corporation, Siemens Healthineers, McKesson Corporation, Elekta, Epic Systems, Cerner Corporation, NextGen Healthcare, SCC Soft Computer, Elekta Oncology, Varian Medical Systems, GE Healthcare, Philips Healthcare, Meditech, Agfa HealthCare. Carestream Health, eClinicalWorks, and iSOFT Group.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

  • Oncology, allowing it to match patients to suitable clinical trials based on their medical data. This collaboration with cancer registries could greatly improve patient access to potentially life-saving clinical trials.
  • In November 2023, C/NET Solutions, a prominent cancer registry software provider, announced a partnership with pharmaceutical giant Roche to develop real-world data solutions for cancer research and treatment. The collaboration aims to leverage C/NET's OncologyOne platform and Roche's expertise in oncology data analytics.
  • In October 2023, McKesson, a renowned healthcare IT business, acquired eHealth Technologies, a cloud-based cancer registry software vendor (eCancerRegistry). This transaction boosts McKesson's oncology offering and broadens its presence in the cancer registry market.
  • In September 2023, Elekta and IBM Watson Health collaborated to create a data interchange platform for cancer registries. This technology will enable the secure sharing of patient data between cancer centers, hence boosting research and tailored care initiatives.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL CANCER REGISTRY SOFTWARE MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL CANCER REGISTRY SOFTWARE MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis

5 GLOBAL CANCER REGISTRY SOFTWARE MARKET, BY TYPE

  • 5.1 Overview
  • 5.2 Integrated Software
  • 5.3 Standalone Software

6 GLOBAL CANCER REGISTRY SOFTWARE MARKET, BY DATABASE

  • 6.1 Overview
  • 6.2 Commercial Databases
  • 6.3 Public Databases

7 GLOBAL CANCER REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY

  • 7.1 Overview
  • 7.2 Cancer Reporting
  • 7.3 Patient Care Management
  • 7.4 Product Outcome Evaluation
  • 7.5 Medical Research and Clinical Studies

8 GLOBAL CANCER REGISTRY SOFTWARE MARKET, BY END USER

  • 8.1 Overview
  • 8.2 Government Organizations & Third-Party Administrators
  • 8.3 Hospitals & Medical Practices
  • 8.4 Private Payers
  • 8.5 Pharmaceutical, Biotechnology, and Medical Device Companies
  • 8.6 Research Centre

9 GLOBAL CANCER REGISTRY SOFTWARE MARKET, BY GEOGRAPHY

  • 9.1 Overview
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 U.K.
    • 9.3.3 France
    • 9.3.4 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Rest of Asia Pacific
  • 9.5 Rest of the World
    • 9.5.1 Latin America
    • 9.5.2 Middle East & Africa

10 GLOBAL CANCER REGISTRY SOFTWARE MARKETCOMPETITIVE LANDSCAPE

  • 10.1 Overview
  • 10.2 Company Market ranking
  • 10.3 Key Development Strategies

11 COMPANY PROFILES

  • 11.1 C/NET Solutions
    • 11.1.1 Overview
    • 11.1.2 Financial Performance
    • 11.1.3 Product Outlook
    • 11.1.4 Key Developments
  • 11.2 IBM Corporation
    • 11.2.1 Overview
    • 11.2.2 Financial Performance
    • 11.2.3 Product Outlook
    • 11.2.4 Key Developments
  • 11.3 Siemens Healthineers
    • 11.3.1 Overview
    • 11.3.2 Financial Performance
    • 11.3.3 Product Outlook
    • 11.3.4 Key Developments
  • 11.4 McKesson Corporation
    • 11.4.1 Overview
    • 11.4.2 Financial Performance
    • 11.4.3 Product Outlook
    • 11.4.4 Key Developments
  • 11.5 Elekta
    • 11.5.1 Overview
    • 11.5.2 Financial Performance
    • 11.5.3 Product Outlook
    • 11.5.4 Key Developments
  • 11.6 Epic Systems
    • 11.6.1 Overview
    • 11.6.2 Financial Performance
    • 11.6.3 Product Outlook
    • 11.6.4 Key Developments
  • 11.7 Cerner Corporation
    • 11.7.1 Overview
    • 11.7.2 Financial Performance
    • 11.7.3 Product Outlook
    • 11.7.4 Key Developments

12 KEY DEVELOPMENTS

  • 12.1 Product Launches/Developments
  • 12.2 Mergers and Acquisitions
  • 12.3 Business Expansions
  • 12.4 Partnerships and Collaborations

13 Appendix

  • 13.1 Related Research